Feng Wan
Papers
1
Total Citations
3
H-Index
1
About
Feng Wan is an emerging researcher at the forefront of peptide chemistry and automated synthesis technologies. His most notable work centers on the development of innovative methodologies for cyclic peptide synthesis — a challenging frontier that bridges the gap between biological macromolecules and small-molecule therapeutics. His landmark contribution, "Automated Rapid Synthesis of High-Purity Head-to-Tail Cyclic Peptides via a Diaminonicotinic Acid Scaffold" (2025), introduced CycloBot, a robotic platform that revolutionizes the speed and efficiency of cyclic peptide production, bringing synthetic chemistry closer to parity with ribosomal biosynthesis. This work, already accumulating citations shortly after publication, addresses a long-standing bottleneck in drug discovery by enabling rapid access to structurally stable, highly specific peptide-based candidates. Cyclic peptides uniquely combine the target selectivity of biologics with the tunability of small molecules, making Wan's advances particularly significant for therapeutic development. Though early in his career, Wan's research demonstrates a compelling integration of automation, scaffold design, and synthetic chemistry, positioning him as a promising contributor to next-generation peptide drug discovery pipelines.
Research Focus
Key Achievements
Top Papers
- 1